Ast, V., Kordaß, T., Oswald, M., Kolte, A., Eisel, D., Osen, W., . . . König, R. (2018). MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion. OncoTarget, 9(85), . https://doi.org/10.18632/oncotarget.26263
Chicago-Zitierstil (17. Ausg.)Ast, Volker, Theresa Kordaß, Marcus Oswald, Amol Kolte, David Eisel, Wolfram Osen, Stefan B. Eichmüller, Alexander Berndt, und Rainer König. "MiR-192, MiR-200c and MiR-17 Are Fibroblast-mediated Inhibitors of Colorectal Cancer Invasion." OncoTarget 9, no. 85 (2018). https://doi.org/10.18632/oncotarget.26263.
MLA-Zitierstil (9. Ausg.)Ast, Volker, et al. "MiR-192, MiR-200c and MiR-17 Are Fibroblast-mediated Inhibitors of Colorectal Cancer Invasion." OncoTarget, vol. 9, no. 85, 2018, https://doi.org/10.18632/oncotarget.26263.